title: [Use of prodigiozan and tactivin for treatment of patients with chronic Klebsiella infections].
abstract: Two-stage immunocorrection in patients with chronic Klebsiella infections by consecutive administration of prodigiozan and tactivin, has been shown to facilitate the restoration of the balance of immunoregulating cells, to enhance proliferative response to T- and B-mitogens, thus producing favorable clinical dynamics. The possibility of chronic Klebsiella infections therapy, based on the use of immunocorrecting preparations (prodigiozan and tactivin) and antibiotics capable of intracellular penetration (sumamed and cyprofloxacin) is discussed.
authors.affiliation: Medical Institute, Clinical Hospital No. 4, Minsk, Belarus.
authors.forename: L P
authors.initials: LP
authors.lastname: Titov
authors.forename: Zh G
authors.initials: ZhG
authors.lastname: Shaban
authors.forename: A I
authors.initials: AI
authors.lastname: Kartel'
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D015703:Antigens, CD / Q000032:analysis / Q000276:immunology; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D006801:Humans; D007109:Immunity / Q000187:drug effects; D016130:Immunophenotyping; D007710:Klebsiella Infections / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000276:immunology*; D010455:Peptides / Q000008:administration & dosage*; D011354:Prodigiozan / Q000008:administration & dosage*; D013949:Thymus Extracts / Q000008:administration & dosage*
chemical_list: D000276:Adjuvants, Immunologic; D015703:Antigens, CD; D010455:Peptides; D013949:Thymus Extracts; C036191:T-activin; D011354:Prodigiozan